Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
New Melocules

CAL-101 870281-82-6 Idelalisib

CAL-101 870281-82-6 Idelalisib

Idelalisib is used for the treatment of chronic lymphocytic leukemia. The substance acts as a phosphoinositide 3-kinase inhibitor; more specifically, it blocks P110δ, the delta isoform of the enzyme phosphoinositide 3-kinase.

GMP for CAL-101 870281-82-6 Idelalisib is not available yet, DMF for CAL-101 870281-82-6 Idelalisib is under preparation
 
Disclaimer:Those products (CAL-101 870281-82-6 Idelalisib) patented are for lab analytical & research purposes only.